Vantage Health, a development stage company, through its wholly-owned South African subsidiary, Moxisign (PTY) Ltd, focuses on operating as a pharmaceutical manufacturer with an intention of bidding on South African government health care contracts and tenders. These include HIV/AIDS medications and other health related government tenders, including medical equipment, TB drugs, and other medical equipment. The company intends to build and operate an active pharmaceutical ingredient (API) manufacturing plant alongside a formulation and packaging plant in South Africa to meet the growing market need for generic medicines, such as HIV/AIDS and chronic disease, in South Africa and the neighboring African countries. It has also approached a national pharmacy chain to supply them with over-the-counter treatments and medications. The company intends to expand its governmental and private sector customer base. It is in the process of forming a special purpose vehicle to build and operate an API pharmaceutical manufacturing facility. In March 2013, the company entered into a distribution agreement with The Himalaya Drug Company (Pty) Ltd. This agreement gives the company the privilege of distributing herbal pharmaceuticals in South Africa. Regulation The company is subject to the financial restrictions and control of the South African Reserve Bank. History Vantage Health was founded in 2010. The company was incorporated in the state of Nevada in 2010.
(VNTH:OTC Markets Group Inc - OTCQB)
401 Warren Street
Redwood City, CA 94063
|No competitor information is available for VNTH.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact VANTAGE HEALTH, please visit www.vantagehealthinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.